Rotech Healthcare Inc.: Represented an ad hoc group of first lien lenders, including Silver Point Finance, LLC and Capital Research & Management Company, in Rotech’s ongoing chapter 11 case.

Hanger Orthopedic Group/NovaCare Orthotics and Prosthetics, Inc.: Represented bridge loan commitment and 144A offering of $150 million of senior subordinated notes of Hanger in connection with its acquisition of NovaCare.

ReAble Therapeutics: Provided senior executive representation for ReAble, a leading medical device company in the rehabilitation and orthopedics markets.

PerkinElmer, Inc.: Advised on a transaction involving a $350 million cross-border financing for Massachusetts-based PerkinElmer, a global provider of advanced technology solutions that address critical health and safety concerns, and its subsidiaries.

Johnson & Johnson: Successfully represented this multinational manufacturer of healthcare, personal hygiene and pharmaceutical products.

Medical Devices: Represented a leading manufacturer of medical devices in multiple patent infringement cases.

Medical Devices: Represented a medical device manufacturer in a lawsuit for trade secret misappropriation and patent infringement. The plaintiff voluntarily dismissed his patent infringement claim with prejudice rather than defend against a motion for summary judgment of patent invalidity. The Sixth Circuit then unanimously affirmed the grant of summary judgment of no trade secret misappropriation.

Philips Medical Systems: Successfully represented Philips Medical Systems in enforcing and defending against 21 patents relating to several different facets of automatic external defibrillator (AED) technology.

AdaptHealth/DFB Healthcare: Represented home medical equipment company AdaptHealth in its business combination with special purpose acquisition company DFB Healthcare Acquisitions Corp.

CVC/Sebia: Represented CVC Capital Partners Strategic Opportunities (CVC Stratops) on its acquisition, alongside Téthys Invest, of a controlling stake in Sebia from Astorg and Montagu Private Equity.

exocad GmbH/The Carlyle Group: Represented the shareholders of exocad GmbH, an independent developer of dental software solutions, in the sale of a majority stake to The Carlyle Group as well as certain shareholders on their reinvestment.

Hansen Medical/Auris Surgical Robots: Advised funds owned by Oracle Management and other majority stockholders of Hansen Medical, Inc. in the acquisition of Hansen Medical by Auris Surgical Robotics, Inc., as well as the related re-investment by such stockholders of their proceeds into Auris.

IK Investment Partners/Marle: Represented IK Investment Partners in its agreement to acquire orthopedic implant manufacturing company Marle from The Carlyle Group.

Insight Venture Partners/CentralReach: Represented Insight Venture Partners in its significant investment in electronic health record and practice management provider CentralReach.  

Kinnser Software/Insight Venture Partners/Mediware: Represented Kinnser Software, Inc., the leading provider of software solutions for home health and hospice providers, and Insight Venture Partners in the sale of Kinnser to TPG Capital-backed Mediware Information Systems, Inc.  

PAI Partners/ELITech: Represented PAI Partners in its acquisition of ELITech Group, a leading manufacturer of specialty in-vitro diagnostics equipment and reagents, from Ergon Capital.

Sagard/Sterimed: Represented Sagard in its acquisition of Sterimed, a leading manufacturer of sterile packaging for the pharmaceutical industry, from Meeschaert Capital Partners.

Salient CRGT/Information Innovators: Represented Bridge Growth Partners, LLC and Salient CRGT in Salient CRGT’s acquisition of Information Innovators, Inc., a technology and mission-focused company serving the federal government, with particular strength in the healthcare IT arena.

Tornier N.V./Wright Medical Group: Represented Tornier N.V., a designer, manufacturer and marketer of joint replacement devices, in its $3.3 billion merger with Wright Medical Group, Inc.

Valtech Cardio/Edwards Lifesciences Corporation: Represented Valtech Cardio in its acquisition by Edwards Lifesciences Corporation for up to $690 million. 

Virgin Pulse/Marlin Equity Partners: Represented Virgin Pulse in its sale to Marlin Equity Partners.  

Warburg Pincus: Represented Warbug in a number of significant acquisition-related transactions with the following medical technology companies:

• Accumetrics: Advised Warburg and ITC Nexus Holding Company in the acquisition of Accumetrics, a global leader in assessing patient response to all major antiplatelet therapies.
• Aircast, Inc.: Represented Warburg and Credit Suisse First Boston in connection with investments in this leading global provider.
• Constitutional Medical Inc./Roche Diagnostics: Represented CMI and Warburg in the sale of CMI to Roche Diagnostics.